perhexiline has been researched along with Myositis Ossificans in 2 studies
Perhexiline: 2-(2,2-Dicyclohexylethyl)piperidine. Coronary vasodilator used especially for angina of effort. It may cause neuropathy and hepatitis.
Myositis Ossificans: A disease characterized by bony deposits or the ossification of muscle tissue.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitoh, H | 2 |
| Achiwa, M | 1 |
| Kaneko, H | 1 |
| Mishima, K | 1 |
| Matsushita, M | 2 |
| Kadono, I | 1 |
| Horowitz, JD | 1 |
| Sallustio, BC | 1 |
| Ohno, K | 2 |
| Ishiguro, N | 2 |
| Yamamoto, R | 1 |
| Masuda, A | 1 |
| Ito, M | 1 |
| Katagiri, T | 1 |
| Kawai, T | 1 |
2 other studies available for perhexiline and Myositis Ossificans
| Article | Year |
|---|---|
Perhexiline maleate in the treatment of fibrodysplasia ossificans progressiva: an open-labeled clinical trial.
Topics: Adolescent; Adult; Alkaline Phosphatase; Female; Humans; Male; Myositis Ossificans; Osteocalcin; Per | 2013 |
Clinically applicable antianginal agents suppress osteoblastic transformation of myogenic cells and heterotopic ossifications in mice.
Topics: Activin Receptors, Type I; Animals; Bone Morphogenetic Protein 2; Calcium Channel Blockers; Cell Lin | 2013 |